Abnormal expression of epigenetic enzymes includes overexpression of EZH2 (enhancer of zeste homolog 2), the catalytic subunit of the PRC2 repressive complex that methylates H3K27, associated with tumor progression and poor prognosis in lung cancer [19–22]. Here, EZH2 is linked to lung cancer.